Catalog |
name |
Description |
price |
R-C-5512 |
14:0 PEG PE |
PEG is a hydrophilic polymer that is often used to modify the surface properties of nanoparticles, liposomes,or other drug delivery systems.PEGylation can enhance the stability and biocompatibility of these systems, extend their circulation time in the body,and reduce their immunogenicity.14-carbon acyl chain (lauric acid) provides hydrophobic character to the compound, allowing for its incorporation into lipid bilayers or lipid-based nanoparticle formulations. |
price> |
R-C-5513 |
18:0 PEG350 PE |
PEG is a hydrophilic polymer commonly used to modify the surface properties of nanoparticles, liposomes, or other drug delivery systems. PEGylation can improve the stability and biocompatibility of these systems, prolong their circulation time in the body, and reduce immunogenicity.In the case of 18:0 PEG PE, the 18-carbon acyl chain (stearic acid) provides hydrophobic character to the compound, allowing for its incorporation into lipid bilayers or lipid-based nanoparticle formulations. |
price> |
R-C-5514 |
18:0 PEG550 PE |
PEG is a hydrophilic polymer commonly used to modify the surface properties of nanoparticles, liposomes, or other drug delivery systems. PEGylation can improve the stability and biocompatibility of these systems, prolong their circulation time in the body, and reduce immunogenicity.In the case of 18:0 PEG PE, the 18-carbon acyl chain (stearic acid) provides hydrophobic character to the compound, allowing for its incorporation into lipid bilayers or lipid-based nanoparticle formulations. |
price> |
R-C-5515 |
18:0 PEG750 PE |
PEG is a hydrophilic polymer commonly used to modify the surface properties of nanoparticles, liposomes, or other drug delivery systems. PEGylation can improve the stability and biocompatibility of these systems, prolong their circulation time in the body, and reduce immunogenicity.In the case of 18:0 PEG PE, the 18-carbon acyl chain (stearic acid) provides hydrophobic character to the compound, allowing for its incorporation into lipid bilayers or lipid-based nanoparticle formulations. |
price> |
R-C-5516 |
18:0 PEG PE |
PEG is a hydrophilic polymer commonly used to modify the surface properties of nanoparticles, liposomes, or other drug delivery systems. PEGylation can improve the stability and biocompatibility of these systems, prolong their circulation time in the body, and reduce immunogenicity.In the case of 18:0 PEG PE, the 18-carbon acyl chain (stearic acid) provides hydrophobic character to the compound, allowing for its incorporation into lipid bilayers or lipid-based nanoparticle formulations. |
price> |
R-C-5517 |
18:1 PEG550 PE |
18:1 PEG PE is a PEG lipid used in small unilamellar vesicles such as liposomes with two 18-carbon chain tails with single alkene bonds in both tails to deliver anticancer and antimalarial agents. |
price> |
R-C-5518 |
18:1 PEG750 PE |
18:1 PEG PE is a PEG lipid used in small unilamellar vesicles such as liposomes with two 18-carbon chain tails with single alkene bonds in both tails to deliver anticancer and antimalarial agents. |
price> |
R-C-5519 |
18:1 PEG PE |
18:1 PEG PE is a PEG lipid used in small unilamellar vesicles such as liposomes with two 18-carbon chain tails with single alkene bonds in both tails to deliver anticancer and antimalarial agents. |
price> |
R-C-5522 |
C16 PEG Ceramide CAS:212116-78-4 |
C16 PEG Ceramide, MW 750 CAS: 212116-78-4 is a ceramide PEGylated lipid complex, its acyl chain length is not the same, it is a heterogeneous lipid molecule, wrapped in polyethylene glycol (PEG) combined therapeutic drug in ceramide as liposome carrier, ensuring longer circulation period. |
price> |
R-C-5523 |
C8 PEG Ceramide CAS:212116-76-2 |
C8 PEG Ceramide CAS: 212116-76-2 is a product of sphingolipid metabolism, and its acyl chain length is different. For the research preparation of liposomes and preparation of PEGylated lipoplexes. |
price> |